XCHG Limited XCH
3.23
0.07
2.22%
as of 25 Sep
- Market cap
- $9.2M
- P/E
- —
Follow XCH
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
P/S ratio |
0.00 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
P/Operating CF |
(163.38) | (293.51) | (1,064.14) |
P/B ratio |
36.41 | 0.00 | 0.00 |
Price to Tangible BV |
36.43 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 |
EV/FCF |
0.00 | 0.00 | 0.00 |
Quick Ratio |
1.00 | 1.54 | 0.97 |
Current Ratio |
1.58 | 2.08 | 1.29 |
Net Debt/EBITDA |
0.23 | 1.52 | (0.38) |
Debt/Assets |
15.00% | 15.42% | 44.13% |
Debt/Equity |
0.36 | 0.30 | (0.60) |
Asset Turnover |
0.50 | 0.86 | 0.00 |
Operating CF/Net income |
0.23 | 0.55 | 0.53 |
Capex/Depreciation |
(2.46) | (2.63) | (2.59) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (137.21%) | 1,036.74% | 0.00% | |
| (65.13%) | (26.71%) | 0.00% | |
ROIC |
(196.76%) | (65.12%) | 0.00% |
Return on Tangible Assets |
(209.08%) | (44.89%) | (109.04%) |
Average Days of Receivables |
138.48 | 116.39 | 134.27 |
Research and Development Expense of Revenue |
28.17% | 28.81% | 10.54% |
Selling, General and Administrative Expense of Revenue |
148.46% | 50.07% | 53.12% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
83.43% | 16.66% | 19.36% |
Graham Net Nets |
0.02 | (0.02) | (0.01) |
Graham Number |
0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% |
Revenue per Share |
7.18 | 26.23 | 1.08 |
Operating CF per Share |
(2.15) | (4.48) | (0.16) |
Capex per Share |
(0.19) | (0.38) | (0.01) |
Free Cash Flow per Share |
(2.35) | (4.86) | (0.17) |
Cash per Share |
3.98 | 16.64 | 0.44 |
Shareholders Equity per Share |
5.11 | 18.34 | (0.84) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
5.11 | 18.34 | (0.84) |
Free Cash Flow |
(8.20) | (7.82) | (6.10) |
Working Capital |
13.57 | 28.22 | 9.02 |
Capital Expenditures |
(0.68) | (0.61) | (0.53) |
Net Current Asset Value |
12.31 | 26.78 | (31.25) |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.01 | 0.01 |
Net Profit Margin |
(129.49%) | (31.05%) | (27.16%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.14 | 0.24 | 0.35 |
Cash ROIC |
(24.88%) | (12.55%) | (164.82%) |
Accounts Receivable Turnover |
2.18 | 3.06 | 0.00 |
Accounts Payable Turnover |
1.88 | 3.13 | 0.00 |
Inventory Turnover |
1.58 | 2.93 | 0.00 |
Average Days of Payables |
181.84 | 133.38 | 100.24 |
Days of Inventory on Hand |
254.98 | 133.65 | 116.04 |
Average Receivables |
11.49 | 13.81 | — |
Average Payables |
7.20 | 6.71 | — |
Average Inventory |
8.56 | 7.17 | — |
Average Assets |
49.90 | 49.05 | — |
Average Common Equity |
23.69 | (1.26) | — |
Columns are period end dates · fundamentals updated 23 Sep 2026